Results 181 to 190 of about 1,734 (194)

Foscarnet/maribavir/valganciclovir

Reactions Weekly, 2019
openaire   +1 more source

Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus

Antiviral Research, 2018
exaly  

Maribavir: A Novel Antiviral Agent with Activity Against Cytomegalovirus

Annals of Pharmacotherapy, 2008
exaly  

Maribavir (Livtencity) for cytomegalovirus infection.

The Medical letter on drugs and therapeutics, 2022
openaire   +1 more source

Foscarnet/ganciclovir/maribavir

Reactions Weekly
openaire   +1 more source

Physiologically Based Pharmacokinetic Modeling for Maribavir to Inform Dosing in Drug‐Drug Interaction Scenarios with CYP3A4 Inducers and Inhibitors

Journal of Clinical Pharmacology
Grace Chen, Kefeng Sun, Ingrid Michon
exaly  

Author response to Maribavir: Double edged sword

The Journal of Heart and Lung Transplantation
Emily A. Blumberg, Oliver Witzke, Mark Harber, Faouzi Saliba, Nassim Kamar, Joan Gu, Deepali Kumar, Ricardo M. La Hoz   +7 more
openaire   +2 more sources

Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients

Transplant Infectious Disease
Marilyne Daher, Amy Spallone, Roy F Chemaly   +2 more
exaly  

Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection

Antiviral Research, 2019
exaly  

Successful oral treatment of Ganciclovir resistant cytomegalovirus with Maribavir in the context of primary immunodeficiency: First case report and review

Journal of Clinical Virology, 2017
exaly